1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
3G 
“advisoey committee 
“Sec. 481. (a) There is established the Recombinant 
DXA Advisory Committee which shall carry out the func- 
tions prescribed for it under this part and which shall make 
recommendations to the Secretary for the effective adminis- 
tration of this part. 
“(b) The Advisory Committee shall consist of seven- 
teen members appointed by the Secretary from individuals 
who by virtue of their training or experience are qualified to 
participate in the functions of the 'Advisory Committee. Of 
the individuals appointed as members of the Advisory Com- 
mittee (1) one shall be representative of the interests of 
nonprofessional personnel engaged in recombinant DXA 
activities; (2) one shall be representative of the interests of 
entities engaged in such activities for commercial purposes; 
and (3) and at least nine shall be individuals who are not 
engaged in any recombinant DXA activity and do not have 
a direct financial interest in such an activity. Of those 
nine individuals, four shall be scientists who are knowledge- 
able in the various scientific and medical disciplines neces- 
sary for an evaluation of the potential risks to health and the 
environment presented by recombinant DXA activities, one 
shall be a specialist in public health, one shall have back- 
ground in the ethical concerns involved in biomedical re- 
search, and three shall represent (he interests of (he general 
[ 654 ] 
